Sinopharm Group Co. Ltd.
SHTDY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $14,000,899 | $19,512,137 | $18,563,819 | $17,003,162 |
| Dep. & Amort. | $4,733,692 | $4,430,248 | $4,165,019 | $3,922,058 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$13,242,591 | -$3,864,456 | -$2,073,701 | -$12,101,333 |
| Other Non-Cash | $6,054,015 | -$2,904,899 | $308,650 | $484,198 |
| Operating Cash Flow | $11,546,015 | $17,173,030 | $20,963,787 | $9,308,085 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,460,690 | -$1,959,570 | -$2,417,529 | -$2,255,642 |
| Net Acquisitions | $0 | -$31,855 | -$336,709 | -$488,356 |
| Inv. Purchases | $0 | -$29,066 | -$100,000 | -$75,000 |
| Inv. Sales/Matur. | $0 | $53,058 | $211,530 | $298,627 |
| Other Inv. Act. | -$1,290,235 | $1,022,898 | -$946,914 | $1,253,409 |
| Investing Cash Flow | -$3,750,925 | -$944,535 | -$3,589,622 | -$1,266,962 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9,935,077 | $2,501,277 | $4,745,565 | -$4,785,374 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$2,714,862 | -$2,558,837 | -$2,340,492 | -$2,153,253 |
| Other Fin. Act. | -$4,635,095 | -$7,586,410 | -$8,098,554 | -$7,754,380 |
| Financing Cash Flow | -$17,285,034 | -$7,643,970 | -$5,693,481 | -$14,693,007 |
| Forex Effect | -$5,240 | $2,389 | $11,512 | $3,047 |
| Net Chg. in Cash | -$9,495,179 | $8,586,914 | $11,692,196 | -$6,648,837 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $63,808,538 | $55,221,624 | $43,529,428 | $50,178,265 |
| End Cash | $54,313,359 | $63,808,538 | $55,221,624 | $43,529,428 |
| Free Cash Flow | $9,577,938 | $14,837,180 | $18,546,258 | $7,052,443 |